Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;43(6):702-708.
doi: 10.1038/s41372-023-01649-w. Epub 2023 Mar 27.

Identification of clinical factors associated with timing and duration of spontaneous regression of retinopathy of prematurity not requiring treatment

Affiliations

Identification of clinical factors associated with timing and duration of spontaneous regression of retinopathy of prematurity not requiring treatment

Jamee Schoephoerster et al. J Perinatol. 2023 Jun.

Abstract

Objective: Identify clinical factors that delay or prolong spontaneous regression of retinopathy of prematurity (ROP).

Study design: Secondary analysis of three prospective studies with 76 infants with ROP not requiring treatment, born ≤30 weeks postmenstrual age (PMA) and ≤1500 grams. Outcomes were PMA at greatest severity of ROP (PMA MSROP), at which regression began, at time of complete vascularization (PMA CV), and regression duration. Pearson's correlation coefficients, t-tests, or analyses of variance were calculated.

Results: Increased positive bacterial cultures, hyperglycemia, transfusion volume of platelets and red blood cells and severity of ROP were associated with later PMA MSROP. Positive bacterial cultures, maternal chorioamnionitis, and less iron deficiency were associated with later PMA CV and prolonged regression duration. Slower length gain was associated with later PMA CV. P < 0.05 for all.

Conclusions: Preterm infants with inflammatory exposures or linear growth impairment may require longer surveillance for ROP resolution and complete vascularization.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, et al. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 2018;136:1034–40. - PubMed - PMC - DOI
    1. Khan SI, Ryu WY, Wood EH, Moshfeghi DM, Shah JK, Lambert SR. Retinopathy of prematurity treatment trends from 2003 to 2020 in the United States. Ophthalmology. 2022;129:1216–8. - PubMed - DOI
    1. Repka MX, Palmer EA, Tung B. Involution of retinopathy of prematurity. cryotherapy for retinopathy of prematurity cooperative group. Arch Ophthalmol. 2000;118:645–9. - PubMed - DOI
    1. Ni YQ, Huang X, Xue K, Yu J, Ruan L, Shan HD, et al. Natural involution of acute retinopathy of prematurity not requiring treatment: factors associated with the time course of involution. Invest Ophthalmol Vis Sci. 2014;55:3165–70. - PubMed - DOI
    1. Eliason KJ, Dane Osborn J, Amsel E, Richards SC. Incidence, progression, and duration of retinopathy of prematurity in Hispanic and white non-Hispanic infants. J AAPOS. 2007;11:447–51. - PubMed - DOI

Publication types

LinkOut - more resources